Target intelligence / Profile preview

CDRT15 pseudogene 13 (CDRT15P13)

Target
CDRT15P13
Molecular classification
Other, Pseudogene, noncoding RNA gene
01

Overview

CDRT15 pseudogene 13 (CDRT15P13) is classified as a pseudogene—typically defined as a segment of DNA that resembles a functional gene but has lost its protein-coding ability due to mutations or deletions. Pseudogenes may arise from gene duplications, retrotransposition events, or accumulated mutations that prevent synthesis of active proteins[1][6][10]. CDRT15P13 is related to CDRT15 (CMT1A Duplicated Region Transcript 15), a protein-coding gene on chromosome 17, but unlike its parental gene, CDRT15P13 does not produce functional protein and is not involved in any known therapeutic mechanism or disease association. Pseudogenes like CDRT15P13 may occasionally play regulatory roles at the RNA level in gene networks but there is currently no evidence of such activity or clinical relevance for this locus[1][6][7].

02

Mechanism of action

None (no drugs target the RNA or gene locus of CDRT15P13)

03

Biological functions

CDRT15P13 does not have a defined protein function.Like some pseudogenes, it might play regulatory roles at the RNA level, such as acting as a competing endogenous RNA, antisense RNA, or miRNA decoy, but no specific functions are published for CDRT15P13 itself[6][7].
04

Disease associations

There is no direct evidence of a disease role.By definition, pseudogenes do not encode functional proteins, but recent research suggests RNA transcripts of some pseudogenes can influence cancer, immune responses, or other processes through non-coding mechanisms[6][7].No such role established for CDRT15P13.

Beyond the preview

Go deeper on CDRT15 pseudogene 13 (CDRT15P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDRT15 pseudogene 13 (CDRT15P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call